Tobias Wertheimer Profile
Tobias Wertheimer

@WertheimerT

Followers
236
Following
426
Media
6
Statuses
116

Physician scientist/ group leader hematology/oncology, cancer immunotherapy

Freiburg im Breisgau, Germany
Joined April 2013
Don't wanna be here? Send us removal request.
@WertheimerT
Tobias Wertheimer
27 days
RT @RouvenHoefflin: 🧬 We are hiring a PhD student for our Computational Oncology lab at @Uniklinik_Fr. You will use cutting-edge spatial te….
0
6
0
@WertheimerT
Tobias Wertheimer
6 months
Check out our new review article on spatially resolved single cell technologies and generative modeling and their application in immunology research. Fun collaboration with Avital, Hosna, @YosefLab, @IdoAmitLab and @FlorianIngelfi1 .
Tweet card summary image
onlinelibrary.wiley.com
This review explores the technical advances in single-cell multi-omics technologies alongside the parallel development of generative AI tools to uncover biological insights. By integrating these...
0
24
23
@WertheimerT
Tobias Wertheimer
10 months
RT @rafeequemavoor: Free scientific illustrations for biologists! šŸ˜. @NIH has released a library of 500+ free scientific illustrations to….
0
2K
0
@WertheimerT
Tobias Wertheimer
11 months
RT @FranziBlaeschke: 🧬 We are hiring a PhD student for our lab at @DKFZ and @KiTZ_HD! This is an exciting collaboration project with my for….
0
14
0
@WertheimerT
Tobias Wertheimer
1 year
RT @jclinicalinvest: Is personalized therapy for #leukemia relapse after stem cell transplant possible? @NanaTalva….
0
3
0
@WertheimerT
Tobias Wertheimer
1 year
If you’re excited about working at the intersection between wet and dry lab to better understand relapse after allo-HCT, consider joining our group for a PhD 😊.
0
3
7
@WertheimerT
Tobias Wertheimer
1 year
RT @YosefLab: We are hiring a software engineer! An amazing opportunity to join our team - be at the core of the development and maintenanc….
linkedin.com
Posted 10:52:32 AM. Yosef lab is looking for Senior software engineer.We are looking for a senior software engineer…See this and similar jobs on LinkedIn.
0
20
0
@WertheimerT
Tobias Wertheimer
2 years
Very excited to share our work on IL-23 and it’s role on Tregs in the TME now out @NatImmunol. A great team effort with @PascaleZwicky @BecherLab and @TuguesLab and many more. Very grateful to everyone who made this possible!!!.
8
1
27
@WertheimerT
Tobias Wertheimer
2 years
Excited to share our work on Tregs in the TME at this fantastic conference #CICON23! @BecherLab @TuguesLab @PascaleZwicky @AACR @ENCI_network @CancerResearch
Tweet media one
1
5
46
@WertheimerT
Tobias Wertheimer
2 years
RT @LAB_BIOC: Excited to kick off the science debates on how to overcome resistance in #Immunotherapy today at #CICON23 hosted by @CancerRe….
0
4
0
@WertheimerT
Tobias Wertheimer
2 years
RT @gheimberg: šŸ“£ Code for SCimilarity is now available! Adapt our demos to your own queries and find similar cells across our 22.7M cell re….
Tweet card summary image
github.com
A unifying representation of single cell expression profiles that quantifies similarity between expression states and generalizes to represent new studies without additional training. - Genentech/s...
0
27
0
@WertheimerT
Tobias Wertheimer
2 years
RT @YvanSaeys: Ever wondered what the equivalent of differential gene expression is for cell-cell communication ?.Look no further. it's Mu….
0
127
0
@WertheimerT
Tobias Wertheimer
2 years
RT @CellCellPress: In the latest issue! Dynamic CD8+ TĀ cell responses to cancer immunotherapy in human regional lymph nodes are disrupted i….
Tweet card summary image
cell.com
A study of CD8+ TĀ cell populations in human head and neck squamous cell carcinomas identifies a role for lymph nodes in modulating anti-tumor responses in response to immunotherapy.
0
32
0
@WertheimerT
Tobias Wertheimer
3 years
RT @ThorstenZenz: Precision Medicine made in ZH/CH.
0
3
0
@WertheimerT
Tobias Wertheimer
3 years
RT @SciImmunology: Agonist #immunotherapy with engineered IL-18 following allogeneic bone marrow transplant in mice improved anti-tumor act….
0
19
0
@WertheimerT
Tobias Wertheimer
3 years
RT @VincentRK: After seeing vorinostat, panobinostat, elotuzumab, belantamab, venetoclax, melflufen, selinexor, ixazomib falter in myeloma,….
0
102
0
@WertheimerT
Tobias Wertheimer
3 years
Poster session with a view @MimZurich retreat. Thanks for the invitation. Great to be part of this!
Tweet media one
0
0
16